Extraction of Loperamide and N-Desmethyl Loperamide from Blood Followed by LC–MS/MS Analysis
The Application Notebook
This application note outlines a simple three-step method for the extraction of loperamide and its main metabolite, N-desmethyl loperamide, from blood. UCT’s Clean Screen® XCEL I column provides users with the same level of sample clean-up as traditional SPE while allowing the elimination of timely conditioning and wash steps.
Loperamide is an over-the-counter antidiarrhoeal drug that has been considered to be safe when used as directed. However, as the opioid epidemic continues to ravage our nation there has been an increasing number of reported cases of loperamide overdose. This application note outlines a simple three-step method for the extraction of loperamide and its main metabolite, N-desmethyl loperamide, from blood. UCT’s Clean Screen® XCEL I column provides users with the same level of sample clean-up as traditional SPE while allowing the elimination of timely conditioning and wash steps.
Procedure
Sample Pretreatment
- To 1 mL blood sample add 3 mL acetate buffer pH 5 and appropriate amount of internal standard.
- Vortex samples for 30 s to mix.
SPE Procedure
- Apply samples to SPE tubes without any preconditioning.
- Allow samples to flow through the column at a rate of 1–2 mL/min.
- Wash samples with 2 mL of D.I. H2O.
- Wash SPE column with 2 mL of 98:2 methanol–glacial acetic acid.
- Dry column for 5 min at full vacuum or pressure.
- Wash samples with 2 mL of hexane.
- Dry column for 10 min at full vacuum or pressure.
- Elute compounds with 2 mL of 78:20:2 DCM–IPA–NH4OH.
- Collect eluate at a rate of 1–2 mL/min.
- Evaporate to dryness at < 50 °C.
- Reconstitute sample in mobile phase.
Instrumental
LC–MS/MS: Thermo Scientific™ Dionex™ 3000 (LC) TSQ Vantage™ (MS/MS)
Column: UCT Selectra® DA HPLC Column 100 × 2.1 mm, 1.8-μm
Guard Column: UCT Selectra® DA Guard Column 10 × 2.1 mm, 1.8-μm
Injection Volume: 1 μL
Mobile Phase A: D.I. H2O + 0.1% formic acid
Mobile Phase B: Acetonitrile + 0.1% formic acid
Column Flow Rate: 0.30 mL/min
Results
Conclusion
This application note effectively outlines a simple three-step method for the extraction of loperamide and its main metabolite, N-desmethyl loperamide, from blood. UCT’s Clean Screen® XCEL I column provides users with the same level of exceptional sample clean-up as traditional SPE while allowing the elimination of timely conditioning and wash steps in addition to a concentration step. Sample extracts are analyzed via UHPLC–MS/MS utilizing UCT’s Selectra® C18 1.8 µm analytical column.
UCT, LLC
2731 Bartram Rd, Bristol, Pennsylvania 19007 USA
Tel.: (800) 385 3153
Website: www.unitedchem.com
Profiling Volatile Organic Compounds in Whisky with GC×GC–MS
November 1st 2024Researchers from Austria, Greece, and Italy conducted a study to analyze volatile organic compounds (VOCs) present in Irish and Scotch whiskys using solid-phase microextraction (SPME) Arrow with comprehensive two-dimensional gas chromatography coupled to mass spectrometry (GC×GC–MS) to examine the organoleptic characteristics that influence the taste of spirits.
GC–MS Targeted Analysis of PFAS Helps Expand Knowledge of Toxicokinetic Data
November 1st 2024Limited toxicokinetic and toxicologic information is available about a diverse set of per- and polyfluoroalkyl substances (PFAS), but methods based on gas chromatography–tandem mass spectrometry (GC–MS/MS) can help unravel some of the mystery.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
